Health
Regeneron suspends Covid-19 antibody trial among sickest patients – Macau Business
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients
US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its Covid-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the results and advises when it’s necessary to halt a study.
“Based on a potential safety signal and an unfavorable risk/benefit profile at this time, the IDMC recommends further enrollment of patients…
-
General22 hours agoShark attack at Tathra Beach leaves 9yo surfer’s board in pieces
-
Noosa News23 hours agoUnborn baby boy fighting for life after 38-week pregnant woman and partner hit by racing P-platers on the Gold Coast
-
Noosa News10 hours agoQueensland government looks to increase Spanish mackerel catch limits
-
Noosa News23 hours agoTruck driver dies after vehicle smashes into Queensland retirement home